QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ripp, S. L. Articles by Prough, R. A. Search for Related Content PubMed PubMed Citation Articles by Ripp, S. L. Articles by Prough, R. A.

Regulation of CYP2C11 by Dehydroepiandrosterone and Peroxisome Proliferators: Identification of the Negative Regulatory Region of the Gene

Department of Biochemistry and Molecular Biology, University of Louisville School of Medicine, Louisville, Kentucky

Treatment of rats with peroxisome proliferators is known to affect gene expression, including suppression of CYP2C11. The current study examined the mechanism of negative regulation of CYP2C11, comparing the effects of a classic peroxisome proliferator, nafenopin, with those of the steroid dehydroepiandrosterone (DHEA). In vivo dose-response experiments for DHEA were carried out with rats. Only the highest dose of DHEA in the diet (0.45%), a dose previously shown to produce peroxisome proliferation, caused suppression of CYP2C11 expression. Lower doses of DHEA (0.012 to 0.20% in diet) had little effect on CYP2C11 expression. In HepG2 cells, negative regulation of a CYP2C11 reporter gene by nafenopin required coexpression of PPAR, whereas negative regulation by DHEA did not. Deletion analysis revealed that the responsive region for both DHEA and nafenopin was between -108 and -60 relative to the transcription start site. Mutations in several putative transcription factor binding sites in the 5'-flanking region of CYP2C11 were produced. A mutation at -121 bp significantly diminished basal expression of CYP2C11 but did not affect negative regulation by DHEA or nafenopin. A mutation at -75 bp had only a small effect on basal expression but completely abolished negative regulation by DHEA and nafenopin. Gel shift experiments indicated that PPAR/RXR heterodimers do not bind DNA in this region. Therefore, the sequence at -75 bp of CYP2C11 is necessary for negative regulation by both DHEA and nafenopin. However, the upstream events leading to suppression at this site must differ for DHEA and nafenopin.

Address correspondence to: Dr. Russell A. Prough, Department of Biochemistry and Molecular Biology, University of Louisville School of Medicine, Louisville, KY 40292. E-mail: russ.prough{at}louisville.edu

This article has been cited by other articles:

				V. Tamasi, K. K. M. Miller, S. L. Ripp, E. Vila, T. E. Geoghagen, and R. A. Prough Modulation of Receptor Phosphorylation Contributes to Activation of Peroxisome Proliferator Activated Receptor {alpha} by Dehydroepiandrosterone and Other Peroxisome Proliferators Mol. Pharmacol., March 1, 2008; 73(3): 968 - 976. [Abstract] [Full Text] [PDF]

				K. C. Falkner, J. K. Ritter, and R. A. Prough Regulation of the Rat UGT1A6 by Glucocorticoids Involves a Cryptic Glucocorticoid Response Element Drug Metab. Dispos., February 1, 2008; 36(2): 409 - 417. [Abstract] [Full Text] [PDF]

				K. Kohalmy, V. Tamasi, L. Kobori, E. Sarvary, J.-M. Pascussi, P. Porrogi, D. Rozman, R. A. Prough, U. A. Meyer, and K. Monostory Dehydroepiandrosterone Induces Human CYP2B6 through the Constitutive Androstane Receptor Drug Metab. Dispos., September 1, 2007; 35(9): 1495 - 1501. [Abstract] [Full Text] [PDF]

				V. Y. Ng, Y. Huang, L. M. Reddy, J. R. Falck, E. T. Lin, and D. L. Kroetz Cytochrome P450 Eicosanoids are Activators of Peroxisome Proliferator-Activated Receptor {alpha} Drug Metab. Dispos., July 1, 2007; 35(7): 1126 - 1134. [Abstract] [Full Text] [PDF]

				A. A. Spector and A. W. Norris Action of epoxyeicosatrienoic acids on cellular function Am J Physiol Cell Physiol, March 1, 2007; 292(3): C996 - C1012. [Abstract] [Full Text] [PDF]

				J. C. Corton and P. J. Lapinskas Peroxisome Proliferator-Activated Receptors: Mediators of Phthalate Ester-Induced Effects in the Male Reproductive Tract? Toxicol. Sci., January 1, 2005; 83(1): 4 - 17. [Abstract] [Full Text] [PDF]

				D. S. Riddick, C. Lee, A. Bhathena, Y. E. Timsit, P.-Y. Cheng, E. T. Morgan, R. A. Prough, S. L. Ripp, K. K. M. Miller, A. Jahan, et al. TRANSCRIPTIONAL SUPPRESSION OF CYTOCHROME P450 GENES BY ENDOGENOUS AND EXOGENOUS CHEMICALS Drug Metab. Dispos., April 1, 2004; 32(4): 367 - 375. [Abstract] [Full Text] [PDF]

				K. K. M. Miller, J. Cai, S. L. Ripp, W. M. Pierce Jr., T. H. Rushmore, and R. A. Prough STEREO- AND REGIOSELECTIVITY ACCOUNT FOR THE DIVERSITY OF DEHYDROEPIANDROSTERONE (DHEA) METABOLITES PRODUCED BY LIVER MICROSOMAL CYTOCHROMES P450 Drug Metab. Dispos., March 1, 2004; 32(3): 305 - 313. [Abstract] [Full Text] [PDF]